首页> 外国专利> AMMONIUM SALTS AND AMMONIUM SALT/MINERAL SALT CLATHRATE COMPOUNDS FOR USE AS VEHICLE AND EFFECTIVE FORM FOR PHARMACO-MEDICAL APPLICATIONS AND FOR USE AS PHASE TRANSFER AGENTS FOR CHEMICAL APPLICATIONS

AMMONIUM SALTS AND AMMONIUM SALT/MINERAL SALT CLATHRATE COMPOUNDS FOR USE AS VEHICLE AND EFFECTIVE FORM FOR PHARMACO-MEDICAL APPLICATIONS AND FOR USE AS PHASE TRANSFER AGENTS FOR CHEMICAL APPLICATIONS

机译:铵盐和铵盐/矿盐螯合化合物,用作药物和医学应用的车辆和有效形式,以及用作化学应用的相转移剂

摘要

This invention relates to ammonium salts and stable storable ammonium salts and ammonium salt/mineral salt clathrate compounds (inclusion compounds, clusters) having acid dibasic anionic acid residues such as bicarbonate, to methods for producing them and to pharmaco-medical and chemical synthetic applications for said compounds. According to the invention, compounds for pharmaco-medical and chemical synthetic applications are produced which comprise the ammonium salt and ammonium salt/mineral salt clathrate compounds (inclusion compounds, clusters) having acid dibasic anionic acid residues of general formula I with R1, R2, R3 and R4=alkyl and substituted alkyl straight-chain or branched, optionally having an alcohol, ether, silyether, ester, amino or amide function, H or aryl-alkyl, with aryl being an aromatic or heteroaromatic ring having optionally additional substituents, such as alkyl having 1 to 4 C atoms, OH, NR*2 with R*2=O, alkyl with alkyl of between 1 and 4 C atoms or H, COOH, COOR, CN, NO2 and the cationic positive N+ is optionally part of an active agent, Y is a dibasic acid residue of an organic dicarboxylic acid or CO3-, corresponding to HY-=HCO3-, and x=0.5 to 30 represents the number of the mineral salt molecules for clathrate compound formation or 0. In pharmaco-medical applications applies the generalizable effectiveness principle according to which to ammonium salt/mineral salt cluster is used as vehicle and active agent for novel forms of application of nitrogen-containing active agent bases. In chemistry, these agents are used in the synthesis of active agents and valuable products, e.g. of cyclic carbonates.
机译:本发明涉及具有酸性二元阴离子酸残基如碳酸氢盐的铵盐和稳定的可储存铵盐和铵盐/矿盐笼形化合物(包括化合物,簇),涉及它们的生产方法,以及涉及它们的药物,医学和化学合成应用所说的化合物。根据本发明,制备了用于药物医学和化学合成应用的化合物,其包括铵盐和铵盐/矿盐笼形化合物(包括化合物,簇),其具有通式I的酸二元阴离子酸残基,且具有R1,R2, R 3和R 4 =烷基和取代的烷基为直链或支链的,任选具有醇,醚,甲硅烷基醚,酯,氨基或酰胺官能团,H或芳基烷基,其中芳基为具有任选另外的取代基的芳族或杂芳族环,例如作为具有1至4个C原子的烷基,OH,R * 2 = O的NR * 2,具有1至4个C原子的烷基的烷基或H,COOH,COOR,CN,NO2和阳离子正N +为任选的一部分Y为有机二羧酸或CO3-的二元酸残基,对应于HY- = HCO3-,x = 0.5至30表示形成包合物的无机盐分子数或为0。 -医学应用铵盐/矿盐簇被用作载体和活性剂的一种普遍适用的效力原理,用于含氮活性剂碱的新型应用形式。在化学上,这些试剂用于合成活性试剂和有价值的产品,例如环状碳酸酯。

著录项

  • 公开/公告号PL1776333T3

    专利类型

  • 公开/公告日2011-06-30

    原文格式PDF

  • 申请/专利权人 KASCH HELMUT;

    申请/专利号PL20050771150T

  • 发明设计人 REUTER UWE;OETTMEIER RALF;KASCH HELMUT;

    申请日2005-07-20

  • 分类号C07C211/63;

  • 国家 PL

  • 入库时间 2022-08-21 18:05:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号